News Briefing channel feed – Endpoints News

News Briefing channel feed

Ansun Biopharma closes $80M Series B; RedHill Biopharma ties up with Cosmo Pharmaceuticals

6 years ago

After 13% discount Innate Pharma raises $69M; AZTherapies bags $26.3M from Series C financing round

6 years ago

Amarna raises €10M to push gene therapy platform into clinic; Editas Medicine, AskBio join forces

6 years ago

Checkmate Pharmaceuticals brings two new execs on board; Takeda sheds 30 drugs, gains $200M in Acino deal

6 years ago

FDA requests additional time for Flexion's sNDA; Genentech releases data for PhIII study of Rituxan

6 years ago

Northwest Bio still hanging on; Five Prime's latest round of layoffs claims 70

6 years ago

Zantac pulled off shelves due to cancer scare; The end of the road for Motif Bio

6 years ago

Prolific Insilico scores up to $200M deal in China; Researchers retract paper on gene involved in CRISPR baby controversy

6 years ago

Gilead files for filgotinib in Japan; Alzheimer's flop forces some painful next steps at Neurotrope

6 years ago

DBV's peanut allergy patch is finally under FDA review; Ritter swallows bitter pill to explore strategic alternatives

6 years ago

Emma Walmsley joins #MeTooPay; Monopar postpones $40M IPO

6 years ago

NICE fails to endorse Roche's Tecentriq for breast cancer; Elicio closes financing round with $33M

6 years ago

More bad news for Sarepta; Novartis, Microsoft join forces in AI pact

6 years ago

Former Akcea president makes the leap to CEO seat at Avidity Biosciences; Astellas invests $12.5M into two incubators

6 years ago

Merck touts Phase III data for antibacterial Recarbrio; Sanofi to ax 200 jobs in Japan — report

6 years ago

T3 Pharmaceuticals completes second financing round; Moderna, Harvard Medical School to tackle immunological diseases

6 years ago

BioNTech lays out plans for $251M IPO; Trio teams up to form joint lab to research chronic lung diseases

6 years ago

Eli Lilly dishes out first milestone payment for Alzheimer's deal; ADC Therapeutics, Viela Bio set terms for IPO

6 years ago

AstraZeneca vet heads to UK biotech as the new CSO; Mallinckrodt touts positive PhIII data

6 years ago

Astellas/FibroGen's anemia drug for CKD patients approved in Japan; Researchers propose combo to stay ahead of KRAS resistance

6 years ago

Alzheimer’s research in line for $350M boost as Senate proposes $3B hike to NIH budget; Allogene teams up with Stanford researchers

6 years ago

vTv Therapeutics reports additional positive PhII data; Shanghai Henlius prices $410 million IPO at bottom of range

6 years ago

Amgen inks discovery deal with Hummingbird; Merck gains priority review for Ebola vaccine

6 years ago

AstraZeneca's diabetes drug granted fast track designation for heart failure; Verrica sends skin infection treatment to FDA

6 years ago

First page Previous page 45 46 474849 50 51 Next page Last page